Meta-analysis of multi-center transcriptomic profiles and machine learning reveal phospholipase Cβ4 as a Wnt/Ca²+ signaling mediator in glioblastoma immunotherapy
IntroductionGlioblastoma (GBM) is a highly aggressive brain tumor characterized by pronounced invasiveness, rapid progression, frequent recurrence, and poor clinical prognosis. Current treatment strategies remain inadequate due to the lack of effective molecular targets, underscoring the urgent need...
Saved in:
| Main Authors: | Zhaoming Song, Fei Wang, Chen Yang, Yanao Guo, Jinfeng Li, Run Huang, Hongyi Ling, Guosheng Cheng, Zhouqing Chen, Zhanchi Zhu, Zhong Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1610683/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysis
by: Zhaoming Song, et al.
Published: (2025-12-01) -
Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges
by: Yuanyang Sun, et al.
Published: (2025-05-01) -
Identification of SURF4 and RALGAPA1 as promising therapeutic targets in glioblastoma and pan-cancer through integrative multi-omics, CRISPR-Cas9 screening and prognostic meta-analysis
by: Fei Wang, et al.
Published: (2025-04-01) -
Machine learning and multi-omics analysis reveal key regulators of proneural–mesenchymal transition in glioblastoma
by: Can Xu, et al.
Published: (2025-06-01) -
Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy
by: Chen Chen, et al.
Published: (2025-03-01)